Form 4 for KVYO Klaviyo, Inc.
Accepted 2026-02-18 00:00:00 ET · period of report 2026-02-15 · accession 0001470831-26-000164 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-18 | 2026-02-15 | KVYO | Edmond Landon | CLO | F - Tax | $18.60 | -24.6K | 330.8K | -7% | -$456.8K |
| DM | 2026-02-18 | 2026-02-15+ | KVYO | Edmond Landon | CLO | C - Cnv Deriv | — | +22.5K | 341.8K | +7% | — |
| DM | 2026-02-18 | 2026-02-15+ | KVYO | Edmond Landon | CLO | C - Cnv Deriv | $0.00 | -22.5K | 11.1K | -67% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Series A Common Stock | 2026-02-15 | F | D | 24,561 | $18.60 | 330,769 | D | — | — | |
| 2 | Common | Series A Common Stock | 2026-02-15 | C | A | 11,448 | — | 355,330 | D | — | — | (F2) Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |
| 3 | Common | Series A Common Stock | 2026-02-17 | C | A | 11,052 | — | 341,821 | D | — | — | (F2) Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. (F4) Consists of (i) 113,414 shares of Series A Common Stock and (ii) 228,407 unvested RSUs awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. |
| 4 | Derivative | Series B Common Stock | 2026-02-17 | C | D | 11,052 | $0.00 | 0 | D | — · — to — | 11,052 Series A Common Stock | (F2) Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |
| 5 | Derivative | Series B Common Stock | 2026-02-15 | C | D | 11,448 | $0.00 | 11,052 | D | — · — to — | 11,448 Series A Common Stock | (F2) Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |